Endodermal Sinus Tumor: Clinical Trials

2 trials for Endodermal Sinus Tumor, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 unknown. 2 Phase 2, 1 Phase 1, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 22Unknown 2
Phase 11Unknown 1
Phase 31Unknown 1

Follow Endodermal Sinus Tumor: new trials by email Literature Review of Endodermal Sinus Tumor trials Research Report on Endodermal Sinus Tumor

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Gemcitabine, Paclitaxel, Ifosfamide, and Cisplatin in Treating Patients With Progressive or Relapsed Metastatic Germ Cell Tumors
filgrastim, lenograstim, pegfilgrastim - Brain and Central Nervous System Tumors, Extragonadal Germ Cell Tumor
Phase 1 / Phase 2UnknownUniversity of Southampton232006-11-012013-01-23
Combination Chemotherapy in Treating Men With Germ Cell Cancer
bleomycin sulfate, filgrastim, cisplatin - Extragonadal Germ Cell Tumor, Teratoma
Phase 2 / Phase 3UnknownEuropean Organisation for Research and Treatment of Cancer - EORTC4981998-10-012012-03-06

Narrower conditions

Seminoma (2)  ·  Testicular Germ Cell Tumor (2)  ·  Testicular Neoplasms (2)  ·  Carcinoma, Embryonal (1)  ·  Central Nervous System Neoplasms (1)  ·  Ovarian Neoplasms (1)  ·  Teratoma (1)

Broader conditions

Endocrine Gland Neoplasms (2)  ·  Endocrine System Diseases (2)  ·  Genital Diseases (2)  ·  Genital Diseases, Male (2)  ·  Genital Neoplasms, Male (2)  ·  Germinoma (2)  ·  Gonadal Disorders (2)  ·  Male Urogenital Diseases (2)  ·  Mesonephroma (2)  ·  Neoplasms (2)  ·  Neoplasms by Histologic Type (2)  ·  Neoplasms by Site (2)  ·  Neoplasms, Germ Cell and Embryonal (2)  ·  Testicular Diseases (2)  ·  Urogenital Diseases (2)

Interventions

Cisplatin (2)  ·  Filgrastim (2)  ·  Paclitaxel (2)  ·  Bleomycin (1)  ·  Etoposide (1)  ·  Gemcitabine (1)  ·  Ifosfamide (1)  ·  Lenograstim (1)  ·  pegfilgrastim (1)

Sponsors

European Organisation for Research and Treatment of Cancer - EORTC (1)  ·  University of Southampton (1)

Countries

United Kingdom (2)  ·  Austria (1)  ·  Belgium (1)  ·  Denmark (1)  ·  France (1)  ·  Germany (1)  ·  Hungary (1)  ·  Israel (1)  ·  Italy (1)  ·  Netherlands (1)  ·  Norway (1)  ·  Poland (1)  ·  Slovakia (1)  ·  Spain (1)

Top investigators

G. Mead, MD (1)  ·  Ronald De Wit, MD, PhD (1)